Atlas Trials

CAR-T Cell Immunotherapy for HCC Targeting GPC3

Clinical trial NCT02723942 · WITHDRAWN

Trial details

NCT number
NCT02723942
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
GPC3 Positive Hepatocellular CarcinomaCAR-T Cell Immunotherapy
Start date
2015-06-01
Primary completion
2016-08-15
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.